Mipetresgene Autoleucel (Mip-cel)

Mipetresgene Autoleucel · Takara Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mipetresgene Autoleucel (Mip-cel), covering 2026-02-18 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma [Phase 3]

See pricing